This leading investors-only conference in the longevity field will bring together the world’s most renowned longevity experts and private and institutional investors in the heart of the Swiss Alps.
Zug, June 14, 2022 – Longevity Investors Conference (LIC) has the honour of welcoming leading longevity experts and scientists such as George Church (Professor of Genetics, Harvard Medical School), Aubrey de Grey (Chief Science Offices, SENS Research Foundation), Eric Verdin (President & CEO, Buck Institute for Research on Ageing), Nir Barzilai (Director, Institute for Ageing Research, Albert Einstein College of Medicine), Michael Greve (Founder, Forever Healthy Foundation), Evelyne Yehudit Bischof (Associate professor, internal medicine specialist, Longevity physician at Human Longevity Inc.), Alex Zhavoronkov (Founder and CEO at Insilico Medicine), Phil Newman (Founder, First Longevity, Editor-in–Chief Longevity.Technology), Wei-Wu He (Executive Chairman, Human Longevity Inc., Chairman and CEO, CASI Pharmaceuticals Inc., Chairman and Founder, Genetron Health) and many more (announced closer to date)…
The 2022 conference will host keynote speeches, fireside-chats, panel discussions and breakout sessions on topics including biotech, agetech, diagnostics, AI, health prevention, longevity therapies, and finally, investment strategies. Some of the partners include PWC, Credit Suisse, Maximon, Korify Capital, Apollo Health Ventures, Clinique La Prairie, Biolytica, Avea and many more.
The Bellevue Hotel in Gstaad, recently rated the “Hotel of the Year” by the Swiss media, will be the venue for the conference. It will be privatised for the LIC guests ensuring an exclusive networking experience.
The unique event format combines rich content and insights sharing during the day, and numerous opportunities for re-charge and network at the lunches, evening receptions, dinners and longevity experiences taking place during the course of the two days conference.
“There are more and more traditional investors joining the longevity space which creates massive investment opportunities. The special setup of this year’s conference enables not only knowledge exchange but also effective community building which is very unique for the industry and has never happened before to this extent.” says Marc P. Bernegger, one of the driving forces behind the conference. His partner and LIC Co-Founder, Dr. Tobias Reichmuth, adds: “The Longevity industry is experiencing a great momentum, and this is the ideal time to use it in favour of educating and spreading the information to investors. In an ocean of scientific-oriented conferences, a professional and global investor focused longevity conference such as LIC will provide an opportunity for the industry’s top investors and innovators to get acquainted with recent developments and breakthroughs.”
About Longevity Investors Conference (LIC)
The LIC returns for its third annual edition on September 28-30 in Gstaad, Switzerland. The conference attracts world’s top longevity leaders, institutional and private investors, wealthy private investors, family offices and funds in an exclusive setting. For two days, opinion leaders and high-ranking representatives will exchange their knowledge about longevity, talk about trends and attractive investment and business opportunities in the longevity space. The conference will ensure a private atmosphere and the opportunity to establish partnerships with other business leaders and investment opportunities in a unique setting in Le Grand Bellevue, a 5*hotel in Gstaad and one of the most exclusive Swiss mountain resorts.
LIC was initiated by Tobias Reichmuth and Marc P. Bernegger, two successful serial entrepreneurs who among others launched CfC St. Moritz, one of the most exclusive conferences for digital assets.
Find out more and secure your ticket here: www.longevityinvestors.ch
Email us at [email protected] Follow us on Linkedin
Follow us on Twitter Follow us on Instagram
We would like to ask you a small favor. We are a non-profit foundation, and unlike some other organizations, we have no shareholders and no products to sell you. We are committed to responsible journalism, free from commercial or political influence, that allows you to make informed decisions about your future health.
All our news and educational content is free for everyone to read, but it does mean that we rely on the help of people like you. Every contribution, no matter if it’s big or small, supports independent journalism and sustains our future. You can support us by making a donation or in other ways at no cost to you.
Write a comment: